[TNXP] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
10-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 14.09%
YoY- -3.51%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 2,482 3,779 3,989 0 33,902 0 9,739 -59.76%
PBT -14,939 -27,322 -27,975 -28,356 -33,005 -31,680 -28,981 -35.68%
Tax -1,210 -0 -1,216 29,002 -1,790 5,611 -610 57.80%
NP -14,939 -27,322 -27,975 -28,356 -33,005 -34,084 -28,981 -35.68%
Tax Rate - - - - - - - -
Total Cost 17,421 31,101 31,964 28,356 66,907 34,084 38,720 -41.25%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -601.89 -723.00 -701.30 0.00 -100.00 0.00 -291.31 62.14%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -5.91 -27.53 -58.40 -85.71 -102.85 -111.06 -135.52 -87.58%
EPS Diluted -5.91 -27.53 -58.40 -85.71 -102.85 -111.06 -135.52 -87.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.